Trial Profile
Therapeutic Control of Aspirin-Exacerbated Respiratory Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Aspirin
- Indications Aspirin-induced asthma; Asthma; Nasal polyps
- Focus Pharmacodynamics; Therapeutic Use
- 08 Jun 2018 Results (n=40) published in the Journal of Allergy and Clinical Immunology.
- 17 Apr 2018 Status changed from active, no longer recruiting to completed.
- 04 Jan 2017 Status changed from recruiting to active, no longer recruiting.